最新更新 :
19/11/2024
抗癌藥物   Floxuridine  
注射液
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF
   化学式  

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Floxuridine (FUDRT) 美国
兼容性   注射液   兼容性 : Floxuridine              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
分子 溶剂 引用文献
1小時後析出 不相容
注射液 Floxuridine 3 mg/ml
注射液 Allopurinol sodium 3 mg/ml
NaCl 0,9% 307
兼容
注射液 Floxuridine 3 mg/ml
注射液 Amifostine 10 mg/ml
葡萄糖5% 3
兼容
注射液 Floxuridine 3 mg/ml
注射液 Aztreonam 40 mg/ml
葡萄糖5% 99
兼容
注射液 Floxuridine 3 mg/ml
注射液 Etoposide phosphate 5 mg/ml
葡萄糖5% 1410
兼容
注射液 Floxuridine 3 mg/ml
注射液 Filgrastim 30 µg/ml
葡萄糖5% 244
兼容
注射液 Floxuridine 3 mg/ml
注射液 Fludarabine phosphate 1 mg/ml
葡萄糖5% 492
兼容
注射液 Floxuridine 1 >> 4 mg/ml
注射液 Folinate calcium 0.03 >> 0.960 mg/ml
NaCl 0,9% 3694
兼容
注射液 Floxuridine 3 mg/ml
注射液 Gemcitabine hydrochloride 10 mg/ml
NaCl 0,9% 1423
兼容
注射液 Floxuridine 3 mg/ml
注射液 Granisetron hydrochloride 0.05 mg/ml
葡萄糖5% 182
兼容
注射液 Floxuridine 3 mg/ml
注射液 Melphalan 0.1 mg/ml
NaCl 0,9% 169
兼容
注射液 Floxuridine 3 mg/ml
注射液 Ondansetron hydrochloride 1 mg/ml
NaCl 0,9% 334
兼容
注射液 Floxuridine 3 mg/ml
注射液 Paclitaxel 1.2 mg/ml
葡萄糖5% 248
兼容
注射液 Floxuridine 3 mg/ml
注射液 Piperacillin sodium / tazobactam 40/5 mg/ml
葡萄糖5% 81
兼容
注射液 Floxuridine 3 mg/ml
注射液 Sargramostim 10 µg/ml
NaCl 0,9% 335
兼容
注射液 Floxuridine 3 mg/ml
注射液 Teniposide 0.1 mg/ml
葡萄糖5% 905
兼容
注射液 Floxuridine 3 mg/ml
注射液 Thiotepa 1 mg/ml
葡萄糖5% 249
兼容
注射液 Floxuridine 3 mg/ml
注射液 Vinorelbine tartrate 1 mg/ml
NaCl 0,9% 84

  Mentions Légales